R & D

  • img

    ‘P53’ Target Anti-Cancer

    Weizmann Institute Introduces P53 Target Anti-Cancer Drugs

    more
  • img

    Platform Technology [MucoMAX®]

    Oral mucosal immunity medicine development platform technology

    more
  • img

    Platform Technology [HumaMAX®]

    Inside-the-body immunoregulatory platform technology

    more

Business

Bio
-
Medicine

01

Medicine Business

We will improve customer satisfaction
by supplying medicinesinformation
and raw materials effectively.

more
img

Bio
-
Consumer

02

Consumer Business

As a company specialized in developing
new medicines for immunotherapy,
we create reliable products for our customers.

more
img

Product

MOAlifeplus Promise a healthier life
with our products of innovative technology.

img

GROUP COMPANY

Global health care group

MOAlifeplus will become a global health care group
that provides total health care services.

  • 바이오리더스